Case Western Reserve researcher receives $11 million grant to test promising new HIV treatment
WKSU: Rafick-Pierre Sekaly, the Richard J. Fasenmyer Professor of Immunopathogenesis, discussed his work on an innovative treatment for HIV and partnership with California-based Sangamo Therapeutics. Sekaly and Sangamo Therapeutics recently received an $11 million grant from the National Institutes of Health to support his research.
